Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Dynavax Technologies (DVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 409,903
  • Shares Outstanding, K 65,064
  • Annual Sales, $ 8,200 K
  • Annual Income, $ -158,900 K
  • 60-Month Beta 0.60
  • Price/Sales 53.10
  • Price/Cash Flow N/A
  • Price/Book 10.09

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.61
  • Number of Estimates 2
  • High Estimate -0.57
  • Low Estimate -0.64
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +3.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.22 +1.29%
on 04/18/19
8.19 -23.08%
on 05/10/19
-0.13 (-2.02%)
since 04/17/19
3-Month
6.22 +1.29%
on 04/18/19
11.44 -44.93%
on 02/19/19
-4.83 (-43.40%)
since 02/15/19
52-Week
6.22 +1.29%
on 04/18/19
17.50 -64.00%
on 05/18/18
-10.40 (-62.28%)
since 05/17/18

Most Recent Stories

More News
After Yesterday's Decline of 3.15%, Dynavax Technolo Offers Investors Better Value

Dynavax Technolo (NASDAQ:DVAX) traded in a range yesterday that spanned from a low of $6.73 to a high of $6.94. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $6.94...

DVAX : 6.30 (-5.83%)
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 7.46% and -3.94%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

DVAX : 6.30 (-5.83%)
Dynavax Technologies: 1Q Earnings Snapshot

BERKELEY, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Wednesday reported a loss of $39.7 million in its first quarter.

DVAX : 6.30 (-5.83%)
Dynavax Announces First Quarter 2019 Financial Results

-- Conference call to be held today at 4:30 p.m. ET/1:30 p.m. PT

DVAX : 6.30 (-5.83%)
Dynavax Technologies Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 8, 2019 / Dynavax Technologies Corp. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern...

DVAX : 6.30 (-5.83%)
Dynavax Technolo Down 32.6% Since SmarTrend Downtrend Call (DVAX)

SmarTrend identified a Downtrend for Dynavax Technolo (NASDAQ:DVAX) on February 27th, 2019 at $9.95. In approximately 2 months, Dynavax Technolo has returned 32.56% as of today's recent price of $6.71....

DVAX : 6.30 (-5.83%)
Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B(R) [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in Adults With End-Stage Renal Disease

Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vaccines and immuno-oncology therapeutics, today...

DVAX : 6.30 (-5.83%)
Analysts Estimate Dynavax Technologies (DVAX) to Report a Decline in Earnings: What to Look Out for

Dynavax Technologies (DVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DVAX : 6.30 (-5.83%)
Dynavax Technolo Down 33.5% Since SmarTrend Downtrend Call (DVAX)

SmarTrend identified a Downtrend for Dynavax Technolo (NASDAQ:DVAX) on February 27th, 2019 at $9.95. In approximately 2 months, Dynavax Technolo has returned 33.47% as of today's recent price of $6.62....

DVAX : 6.30 (-5.83%)
Dynavax Technologies to Report First Quarter 2019 Financial Results and Host Conference Call on May 8

Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology therapeutics, will report its first...

DVAX : 6.30 (-5.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade DVAX with:

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

2nd Resistance Point 6.73
1st Resistance Point 6.51
Last Price 6.30
1st Support Level 6.18
2nd Support Level 6.07

See More

52-Week High 17.50
Fibonacci 61.8% 13.19
Fibonacci 50% 11.86
Fibonacci 38.2% 10.53
Last Price 6.30
52-Week Low 6.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar